A federal jury in Boston has awarded $88 million to Alabama residents Larry and Tammy Patterson in the first bellwether trial in the federal Covidien hernia mesh litigation.
The August 4, 2026, verdict included $77 million in compensatory damages for Larry Patterson and $11 million for Tammy Patterson’s loss-of-consortium claim. Jurors found that Covidien failed to provide adequate warnings to physicians about risks associated with the Symbotex hernia mesh implanted in Mr. Patterson.
The verdict represents an important development for thousands of people pursuing claims involving Covidien hernia mesh products. It does not, however, determine the outcome or value of any other case.
What Happened to Larry Patterson?
Larry Patterson received a Symbotex hernia mesh implant during a 2017 surgery. Symbotex is manufactured by Covidien, which is now part of Medtronic.
According to evidence presented during the trial, Symbotex incorporated a polyester textile with a collagen barrier intended to minimize direct attachment between the mesh and internal organs. The Pattersons’ attorneys argued that this protective coating dissolved sooner than physicians had been led to expect.
Mr. Patterson subsequently developed severe adhesions involving the mesh and his bowel. He underwent additional surgery during which the mesh and several inches of his intestine were removed. The resulting injuries reportedly left him with serious, lasting gastrointestinal limitations.
After a three-week trial, the jury concluded that Covidien had failed to adequately warn physicians about risks associated with the device. Covidien disputed the allegations and argued that Mr. Patterson’s medical history and other risk factors caused his injuries. ABC 33/40 reported on the verdict and Mr. Patterson’s medical history.
The Jury Awarded Compensatory—but Not Punitive—Damages
The entire $88 million award consisted of compensatory damages. These damages are intended to compensate plaintiffs for losses such as medical expenses, physical pain, permanent impairment, emotional suffering, and the effect an injury has on a marriage.
The jury did not award punitive damages and did not find that Covidien committed fraud. That distinction matters. The verdict reflects the jury’s conclusion that the warnings provided with the product were inadequate without a separate finding that the company acted fraudulently or with the level of misconduct necessary to justify punitive damages.
According to reporting on the trial, the award may be the largest compensatory verdict in the history of U.S. hernia mesh litigation. Covidien and Medtronic have indicated that they disagree with the verdict and may pursue post-trial or appellate remedies. The amount ultimately recovered could therefore be affected by later court proceedings.
Why This Bellwether Verdict Matters
Patterson was the first federal bellwether trial in In re: Covidien Hernia Mesh Products Liability Litigation, MDL No. 3029. The litigation is being coordinated before Judge Patti B. Saris in the U.S. District Court for the District of Massachusetts.
A multidistrict litigation proceeding brings lawsuits sharing common factual issues before one federal judge for coordinated discovery and pretrial proceedings. It is not a class action. Each plaintiff retains an individual claim, and compensation—if any—depends on that plaintiff’s product, medical history, injuries, treatment, applicable law, and supporting evidence.
Bellwether trials allow the parties to see how juries respond to evidence and arguments that may appear in other cases. Their outcomes can influence litigation strategy and settlement discussions, but they do not bind other plaintiffs or guarantee similar verdicts.
The federal litigation included approximately 2,500 pending cases when the Patterson verdict was announced. Thousands of additional Covidien mesh cases are reportedly pending in state courts. The Judicial Panel on Multidistrict Litigation publishes monthly reports documenting the number of cases pending in federal MDLs.
Covidien Polyester Mesh Claims
The Covidien litigation involves products from several hernia mesh lines, including Symbotex, Parietex, and ProGrip. These devices are not identical, and the claims associated with them can involve different designs, coatings, implant techniques, and medical outcomes.
Plaintiffs in the litigation generally allege that certain Covidien mesh products caused or contributed to complications such as:
- Adhesions between the mesh and internal organs
- Bowel obstruction
- Bowel erosion or perforation
- Infection
- Chronic abdominal pain
- Mesh migration, shrinkage, or folding
- Hernia recurrence
- Fistulas or abscesses
- Revision surgery or bowel resection
These remain allegations in the broader litigation. Whether a particular mesh caused an individual patient’s complications requires a review of the operative reports, implant records, imaging, pathology, subsequent treatment, and other medical evidence.
The Patterson verdict should not be treated as an automatic “price” for other Covidien claims. Mr. Patterson experienced an unusually serious bowel injury and underwent major reconstructive surgery. Cases involving different products, complications, or levels of medical treatment may be evaluated very differently.
How Heninger Garrison Davis Is Handling Hernia Mesh Cases
Heninger Garrison Davis represents people injured by allegedly defective medical devices, including hernia mesh. Our attorneys understand that these cases require more than proof that a patient experienced pain after surgery. The correct device must be identified, the medical evidence must be developed, and the relationship between the implant and the claimed injury must be evaluated carefully.
HGD’s work on a potential hernia mesh claim may include:
- Identifying the implanted product. Our team reviews implant records, operative reports, device stickers, and hospital records to determine the manufacturer and model involved.
- Documenting complications and additional treatment. We obtain records relating to infections, adhesions, bowel obstruction, recurrent hernias, mesh removal, revision procedures, and other relevant care.
- Evaluating causation and eligibility. Not every complication following hernia surgery supports a product-liability claim. Our attorneys examine the medical chronology, competing explanations, product information, and applicable law.
- Preserving important evidence. When mesh has been removed, pathology records, photographs, operative findings, and information concerning the explanted device may become important evidence.
- Monitoring the national litigation. HGD follows bellwether trials, court orders, discovery developments, mediation efforts, and other events that may affect clients’ individual cases.
- Keeping clients informed. HGD uses a dedicated client-coordinator model to help clients receive updates and understand the next steps in a complex mass-tort proceeding.
Information about HGD’s hernia mesh practice is available on the firm’s hernia mesh litigation page.
Were You Injured After Receiving Covidien Hernia Mesh?
People who received a Covidien hernia mesh product and later required revision surgery may have legal options. Warning signs that warrant further investigation can include bowel adhesions, obstruction, infection, chronic abdominal pain, mesh migration, hernia recurrence, or removal of part of the intestine.
Because filing deadlines differ by state and may depend on when an injury was discovered, patients should not assume that the existence of an MDL automatically protects their claims.
Heninger Garrison Davis offers free consultations to people who believe they may have been injured by hernia mesh. Contact HGD at (659) 222-4880 to discuss your medical history and learn whether your circumstances may qualify for further review.
This article is provided for general educational purposes and does not constitute legal advice. The Patterson verdict applies only to the Pattersons’ claims and may be subject to post-trial proceedings or appeal. Every case is different, and past results do not guarantee future outcomes.
